It’s TIME for a biomarker-driven approach to cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s40425-016-0147-8
Published Online: 2016-08-16
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Emens, Leisha A.